How does osteoporosis or fracture risk affect your use of CGRP monoclonal antibodies?
In light of AHS Scientific Meeting 2026 abstract OR-01 by Ney et al.
1 Answer
Mednet MemberInvited Expert
Neurology · Greater Boston Headache Center at Boston Advanced Medicine
Answered on
As far as I know, this is a purely theoretical concern. Time will tell, and, in addition, we have very effective treatments available for osteoporosis, if this is an issue.
Join for free or sign in to see the full answer